Evidence map›Paper›PMID 24874543›Full record

ArticleNeurobiology of disease2014

Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model.

Desislava M Doycheva, Tiffany Hadley, Li Li, Richard L Applegate, John H Zhang, Jiping Tang

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Neurobiology of disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. The role of lymphocytes in neonatal encephalopathy.Brain, behavior, & immunity - health · 2021
    Review
  7. Targeting neutrophils as a novel therapeutic strategy after stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  8. Review
  9. Article
  10. Early neutrophil infiltration is critical for inflammation-sensitized hypoxic-ischemic brain injury in newborns.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Desislava M DoychevaDepartment of Physiology & Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Tiffany HadleyDepartment of Anaesthesiology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Li LiDepartment of Physiology & Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Richard L ApplegateDepartment of Anaesthesiology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
John H ZhangDepartment of Physiology & Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA; Department of Neurosurgery, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Jiping TangDepartment of Physiology & Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA. Electronic address: jtang@llu.edu.
Loma Linda University · US

Funding

Harness Germinal Matrix HemorrhageR01NS078755 · NINDS · LOMA LINDA UNIVERSITY · PI ZHANG, JOHN H · 2012 to 2016
$1.7M
Mechanisms of G-CSF-Induced NeuroprotectionR01NS060936 · NINDS · LOMA LINDA UNIVERSITY · PI TANG, JIPING · 2009 to 2012
$1.3M
NINDS NIH HHS NS078755NINDS NIH HHS R01 NS060936NINDS NIH HHS R01NS060936NINDS NIH HHS R01 NS078755
6 · The paper itself

Abstract

objectivesNeonatal hypoxia ischemia (HI) is an injury that can lead to neurological impairments such as behavioral and learning disabilities. Granulocyte-colony stimulating factor (G-CSF) has been demonstrated to be neuroprotective in ischemic stroke however it has also been shown to induce neutrophilia, ultimately exacerbating neuronal injury. Our hypothesis is that coadministration of anti-neutrophil antibody (Ab) with G-CSF will decrease blood neutrophil counts thereby reducing infarct volume and improving neurological function post HI brain injury.

methodsRat pups were subjected to unilateral carotid artery ligation followed by 2.5h of hypoxia. Animals were randomly assigned to five groups: Sham (n=15), vehicle (HI, n=15), HI with G-CSF treatment (n=15), HI with G-CSF+Ab treatment (n=15), and HI with Ab treatment (n=15). Ab (325μg/kg) was administered intraperitoneally while G-CSF (50μg/kg) was administered subcutaneously 1h post HI followed by daily injections for 3 consecutive days. Animals were euthanized at 96h post HI for blood neutrophil counts and brain infarct volume measurements as well as at 5weeks for neurological function testing and brain weight measurements. Lung and spleen weights at both time points were further analyzed.

resultsThe G-CSF treatment group showed tendencies to reduce infarct volume and improve neurological function while significantly increasing neutrophil counts. On the other hand, the G-CSF+Ab group significantly reduced infarct volume, improved neurological function and decreased neutrophil counts. The Ab alone group showed reversal of the neuroprotective effects of the G-CSF+Ab group. No significant differences were found in peripheral organ weights between groups.

conclusionOur data suggest that coadministration of G-CSF with Ab not only prevented brain atrophy but also significantly improved neurological function by decreasing blood neutrophil counts. Hence the neuroprotective effects of G-CSF may be further enhanced if neutrophilia is avoided.

Indexed as

AnimalsAnimals, NewbornAntibodiesAtrophyBrainCombined Modality TherapyDisease Models, AnimalGranulocyte Colony-Stimulating FactorHypoxia-Ischemia, BrainLeukocyte CountLungNeuroprotective AgentsNeutrophilsRandom AllocationRats, Sprague-DawleyRecovery of FunctionAntibodiesGranulocyte Colony-Stimulating FactorNeuroprotective AgentsAnti-neutrophil antibody (Ab)Granulocyte-colony stimulating factor (G-CSF)Hypoxia–ischemia (HI)NeonatalNeurological functionNeutrophil

Identifiers

PMID24874543
PMCPMC4109395
OpenAlexW1983212434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.